Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Abbott Laboratories

3 Healthcare Stocks to Buy Now for a Healthy Portfolio in 2025

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical technology. Hence, investors might consider investing in healthcare stocks, Eli Lilly (LLY), Thermo Fisher Scientific (TMO), and Abbott Laboratories (ABT) for a healthy portfolio in 2025. Read more….

Is Abbott Laboratories Stock Underperforming the Nasdaq?

Is Abbott Laboratories Stock Underperforming the Nasdaq?

Despite Abbott Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.

What Are Wall Street Analysts' Target Price for Abbott Laboratories Stock?

What Are Wall Street Analysts' Target Price for Abbott Laboratories Stock?

Despite Abbott Laboratories’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Medical Device Stocks to Buy for Consistent Growth

The medical devices industry is on the verge of an incoming boom, fueled by its growing demand and technological advancements. In this evolving landscape, investors could scoop up shares of robust medical device stocks Alcon (ALC), Becton, Dickinson (BDX), and Abbott (ABT) for solid gains. Read more….

3 Healthcare Stocks That Can Thrive in Any Economy

The healthcare market shows promise due to heightened demand for quality care, technological advancements, preventive measures, and increased public investment, ensuring resilience in any economic condition. Therefore, investors could now consider top healthcare stocks, such as Eli Lilly (LLY), Merck & Co. (MRK), and Abbott Laboratories (ABT). Keep reading.

3 MedTech Stocks to Watch as Innovation in Healthcare Soars

MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in digital health technologies. Thus, adding strong MedTech stocks like Becton, Dickinson (BDX), Abbott (ABT), and Medtronic (MDT) to your watchlist could be wise as innovation in healthcare accelerates. Read more….

3 Defensive Dividend Aristocrats to Protect and Dominate in 2024

Discover three top defensive dividend stocks to boost your portfolio's resilience and earn consistent returns!

inkl

Read news from The Economist, FT, and more,
with one subscription

3 MedTech Stocks Innovating Healthcare

3 MedTech Stocks Innovating Healthcare

MedTech’s bright future is fueled by rapid tech advancements and increasing demand for medical devices, implants, and precision treatments, driven by an aging population and rising global disease rates. Given this backdrop, adding strong MedTech stocks like Boston Scientific (BSX), Stryker (SYK), and Abbott (ABT) to one’s portfolio could be…

3 Dividend Kings With Massive Dividend Growth Rates

3 Dividend Kings With Massive Dividend Growth Rates

Learn how these three dividend kings can boost your portfolio's income potential.

Nervous About the Market? 3 Defensive Stock Picks to Consider This August

Nervous About the Market? 3 Defensive Stock Picks to Consider This August

Explore three defensive stock picks from the consumer staples, healthcare, and utilities sectors that offer stability amid market uncertainty in August.

Abbott Stock: Is Wall Street Bullish or Bearish?

Abbott Stock: Is Wall Street Bullish or Bearish?

Abbott has lagged the broader market over the past year, but analysts are optimistic about the stock’s prospects.

3 Highest-yielding Dividend Aristocrats With Strong-buy Ratings

3 Highest-yielding Dividend Aristocrats With Strong-buy Ratings

Discover the top three highest-rated, highest-yielding Dividend Aristocrats for your retirement portfolio.

Abbott's Q2 2024 Earnings: What to Expect

Abbott's Q2 2024 Earnings: What to Expect

Abbott is poised to release its second-quarter results this month, and analysts are projecting a slight increase in profits.

3 Healthcare Stocks Set to Benefit From Aging Population Trends

3 Healthcare Stocks Set to Benefit From Aging Population Trends

The healthcare industry is set to grow significantly due to technological advances, an aging population, and increasing demand for quality healthcare. To that end, it could be wise to buy fundamentally strong healthcare stocks like Abbott Laboratories (ABT), Stryker (SYK), and Centene (CNC), which are set to benefit from these…

Get all your
news in one place.

100's of premium titles.
One news app.

3 Top-Rated Dividend Kings Trading Near Their 52-Week Lows

These quality companies all have something in common: They are trading a little off their 52-week lows and pay an ever-increasing dividend.

3 Top S&P 500 Stocks With Strong Analyst Ratings

The S&P 500 index’s 2024 rally continued in June as solid corporate earnings outweighed concerns over slower economic growth and a potential delay in the Fed’s pivot to interest rate cuts. Further, several Wall Street strategists raised their year-end S&P 500 price targets. Hence, top-performing S&P 500 stocks Amazon.com (AMZN),…

Evening Standard

Volatility halts hit numerous NYSE-listed stocks in error

An apparent glitch at the operator of the New York Stock Exchange triggered volatility trading halts shortly after the open in about a dozen companies, including Chipotle Mexican Grill Inc. and Abbott Laboratories.

Abbott Stock: Analyst Estimates & Ratings

Abbott has underperformed the broader market over the past year, but Wall Street analysts are optimistic about the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

3 Near-oversold Dividend Aristocrats To Buy Before They Pop

These three Dividend Aristocrats trade near oversold levels and offer reliable income and potential capital appreciation.

The Guardian - UK

Medical device companies pay millions to NHS while pushing products, says study

Pharmaceutical equipment firms are funding NHS staff and training while promoting sales

Abbott Exceeds Profit Expectations With Strong Medical Device Sales

Abbott Laboratories surpasses profit expectations with strong medical device sales, showcasing market leadership and growth strategies.

3 Passive Income Stocks To Scoop Up Now

These three stocks have earned the title of Dividend Kings by consistently increasing dividends for at least 50 years.

Abbott Laboratories Reports Strong Earnings Despite Recent Challenges

Abbott Laboratories' Q4 earnings report and stock performance analysis, highlighting limited growth potential.

Abbott's 2024 Earnings Forecast Hits Below Estimates, Shares Decline

Abbott predicts lower-than-expected earnings for 2024, causing a decline in its shares. Investors are disappointed with the forecast.

Analyzing 2024 Gain Potential in 3 Medical Stocks

The medical sector is poised for substantial gains this year, fueled by rising cases of chronic diseases and swift technological progress. In light of this, let’s analyze the fundamentals of three medical stocks: Abbott Laboratories (ABT), Agilent Technologies (A), and Viemed Healthcare (VMD). Read on….

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Amazon.com Inc.

Johnson & Johnson (

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Corporate Earnings

Places

403,798 stories

145,654 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play